Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Long-term Safety and Efficacy of Zilucoplan in Myasthenia Gravis: Additional Interim Analyses of RAISE-XT

Author:Howard, James F.   Freimer, Miriam   Genge, Angela   Hewamadduma, Channa   Hussain, Yessar   Maniaol, Angelina   Mantegazza, Renato   Smilowski, Marek   Utsugisawa, Kimiaki   Vu, Tuan   Weiss, Michael   Duda, Petra   Boroojerdi, Babak   Vanderkelen, Mark   De La Borderie, Guillemette   Leite, M. Isabel   

Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S15.002  

Author Institution:Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, Chapel Hill, NC  Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA, Columbus, OH  Clinical Research Unit, The Montreal Neurological Institute, Montreal, QC, Canada, Montreal, QC, Canada  Academic Neuroscience Unit, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK  Sheffield Institute for Translational Neurosciences (SITRAN), University of Sheffield, Sheffield, UK, Sheffield, United Kingdom  Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA, Austin, TX  Department of Neurology, Oslo University Hospital, Oslo, Norway, Oslo, Norway  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  Medical University of Silesia, Katowice, Poland, KATOWICE, Poland  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  Department of Neurology, University of Washington Medical Center, Seattle, WA, USA, Seattle, WA  UCB Pharma, Cambridge, MA, USA, Cambridge, MA  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Braine-l’Alleud, Belgium, Braine L'Alleud, Belgium  UCB Pharma, Brussels, Belgium, Brussels, Belgium  Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK , Oxford, United Kingdom  

Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study